Company / Cash per Share
Adaptimmune Therapeutics PLC Cash per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.07
FY2024
5-year range
$0.07 / $0.16
FY2020-FY2024
Trend
-54.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 9 years, ranging from $0.07 in FY2024 to $0.37 in FY2016.
Based on SEC 10-K filings.
0.07 in FY2024 with a 5-year CAGR of -3.6%.
Declined from $0.12 to $0.07 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -25.5%
- 5-Year CAGR
- -3.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, cash per share decreased 54.2% year-over-year.
- Peak cash per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.07 | -54.2% |
| FY2023 | $0.15 | +25.4% |
| FY2022 | $0.12 | -27.9% |
| FY2021 | $0.16 | +79.1% |
| FY2020 | $0.09 | +12.2% |
| FY2019 | $0.08 | -34.0% |
| FY2018 | $0.12 | -38.5% |
| FY2017 | $0.20 | -47.1% |
| FY2016 | $0.37 | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026